Want to see SOLV full AI Analyst Report?
Operating Income by Segment
Reports profit after operating costs for each segment, showing which parts of Solventum generate the most earnings and where margins are under pressure. Comparing operating income across segments helps investors judge capital allocation, operational efficiency, and where management should prioritize improvements or investments.Underlying segment profitability looks healthier than reported swings: Health Information Systems is the clear growth engine, MedSurg is drifting down modestly, Dental is stabilizing after SKU rationalization, and Purification & Filtration has been exited—explaining its disappearance and the large one‑time gain that produced the Corporate & Unallocated spike. Amortization pressure is easing. Management’s margin targets rely on Transform savings and HIS momentum, but ERP cutover and separation timing will keep quarter-to-quarter volatility elevated.
Date | Other | Corporate & Unallocated | Medsurg | Dental Solutions | Health Information Systems | Purification & Filtration | Amortization Expense |
|---|---|---|---|---|---|---|---|
Jun 30, 2026 | $19.00M | -$378.00M | $355.00M | $131.00M | $145.00M | $0.00 | -$90.00M |
Mar 31, 2026 | $12.00M | -$219.00M | $161.00M | $87.00M | $130.00M | $0.00 | -$90.00M |
Dec 31, 2025 | $11.00M | -$218.00M | $191.00M | $84.00M | $133.00M | $0.00 | -$77.00M |
Sep 30, 2025 | $12.00M | $1.30B | $203.00M | $87.00M | $134.00M | $26.00M | -$77.00M |
Jun 30, 2025 | $0.00 | -$182.00M | $210.00M | $96.00M | $120.00M | $48.00M | -$78.00M |
Mar 31, 2025 | $0.00 | -$195.00M | $206.00M | $78.00M | $109.00M | $35.00M | -$81.00M |
Dec 31, 2024 | $0.00 | -$193.00M | $209.00M | $78.00M | $114.00M | $16.00M | -$88.00M |
Sep 30, 2024 | $0.00 | -$77.00M | $243.00M | $72.00M | $105.00M | $20.00M | -$88.00M |
Jun 30, 2024 | $0.00 | -$104.00M | $214.00M | $90.00M | $111.00M | $19.00M | -$86.00M |
Mar 31, 2024 | $0.00 | -$3.00M | $221.00M | $110.00M | $101.00M | $39.00M | -$87.00M |